Fieldview Capital Management LLC Purchases New Stake in Ventas, Inc. $VTR

Fieldview Capital Management LLC purchased a new stake in Ventas, Inc. (NYSE:VTR) during the 4th quarter, Holdings Channel.com reports. The fund purchased 12,122 shares of the real estate investment trust’s stock, valued at approximately $938,000.

Several other hedge funds have also recently bought and sold shares of the business. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% in the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares during the period. True Wealth Design LLC raised its holdings in Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares during the period. Cigna Investments Inc. New raised its holdings in Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares during the period. Parallel Advisors LLC raised its stake in shares of Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after purchasing an additional 175 shares during the period. Finally, HighTower Advisors LLC raised its stake in shares of Ventas by 0.4% during the third quarter. HighTower Advisors LLC now owns 42,092 shares of the real estate investment trust’s stock valued at $2,946,000 after purchasing an additional 182 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Performance

Ventas stock opened at $84.58 on Monday. The company has a market cap of $41.12 billion, a PE ratio of 153.79, a P/E/G ratio of 1.82 and a beta of 0.71. The company has a fifty day moving average price of $85.15 and a two-hundred day moving average price of $82.51. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. Ventas, Inc. has a 12 month low of $61.76 and a 12 month high of $91.06.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s payout ratio is currently 378.18%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on VTR. Jefferies Financial Group lifted their price objective on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Evercore reiterated an “outperform” rating and set a $95.00 price objective on shares of Ventas in a research note on Wednesday, April 29th. Royal Bank Of Canada lifted their price objective on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price objective on shares of Ventas in a research note on Tuesday, May 19th. Finally, Wells Fargo & Company lifted their price objective on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.19.

Insiders Place Their Bets

In other news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.